Teva to Pay $420M to Settle Shareholder Suit Over Generic Drug Pricing January 19, 2022 By Jody Godoy Teva Pharmaceutical Industries Ltd. has agreed to pay $420 million to settle shareholder litigation alleging the company hid an anti-competitive...
Appeals Court Reinstates Glaxo $235.5 Million Verdict Against Teva October 5, 2020 By Jonathan Stempel A federal appeals court on Friday reinstated a 2017 jury verdict ordering Teva Pharmaceutical Industries Ltd. to pay GlaxoSmithKline Plc...
States’ Lawsuit Accuses 26 Drugmakers of Price Fixing of Generic Drugs June 11, 2020 By Diane Bartz and Jonathan Stempel Twenty-six drug manufacturers were sued on Wednesday by the attorneys general of most U.S. states and several territories, which accused...
Blues Health Insurers Back Venture to Lower Generic Drug Prices January 27, 2020 By Caroline Humer A group of Blue Cross Blue Shield insurers is investing $55 million in a venture that aims to offer cheaper...
44 States Sue Drug Maker Teva, Alleging Price Fixing Scheme with 19 Other Firms May 13, 2019 By Diane Bartz and Doina Chiacu U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc. of orchestrating a sweeping scheme with 19 other drug companies...
How to Keep Big Pharma from Winning Drug Price Wars: Joe Nocera April 9, 2019 By Joe Nocera, Bloomberg Opinion Robin Feldman is a law professor at the University of California Hastings with a particular expertise in antitrust and patent...
Brand Name Drug Maker Not Liable for Injuries from Generic Version: Court August 23, 2018 By Tina Bellon A U.S. appeals court on Wednesday tossed a $3 million verdict against GlaxoSmithKline over the suicide of an attorney who...
Why Patent ‘Shenanigans’ Share Blame for High Cost of Drugs December 29, 2017 By Robert Langreth and Cynthia Koons Bob Kelsey can’t afford a cancer drug that could save his life. The retired firefighter, 53, needs Revlimid to stay...
Court in California Rules Novartis Can Be Sued Over Generic Drug Injuries December 22, 2017 By Nate Raymond California’s top court has opened the door for consumers to sue Novartis AG and other makers of brand-name pharmaceutical products...
Drugs Prices Much Higher in U.S. Than in Other Countries: Research October 12, 2015 By Ben Hirschler U.S. prices for the world’s 20 top-selling medicines are, on average, three times higher than in Britain, according to an...